NewsBenzingaAstraZeneca's Baxfendy Recommended For Approval In EU For Treatment Of Adult Patients Arterial Hypertension Insufficiently Controlled With At Least Two Antihypertensive Medicinal Products AstraZeneca's Baxfendy Recommended For Approval In EU For Treatment Of Adult Patients Arterial Hypertension Insufficiently Controlled With At Least Two Antihypertensive Medicinal Products Benzinga 2026.11.13 11:57 (GMT+0) Open on Benzinga Other news Arthur Hayes: Bullish on ETH, ZEC, NEAR and VVV, Has Built Small- and Mid-Sized Positions Asia shares slide on tech weakness ahead of Nvidia earnings Huang's Nvidia Return Odds Rebound to 11% on Kalshi Hackers Spread Crypto-Stealing Trojan via Fake GTA 6 PC Download Links Invesco's Stablecoin Reserve Fund Goes Live on Ethereum 7 Major US Banks Disclose XRP ETF Holdings in SEC Filings, Totaling About $29.4M